Jusletter

Does the World Anti-Doping Code Revision Live up to its Promises?

A Preliminary Survey of the Main Changes in the Final Draft of the 2015 WADA Code

  • Auteur-e-s: Antonio Rigozzi / Marjolaine Viret / Emily Wisnosky
  • Domaines juridiques: Sport, Arbitrage
  • Proposition de citation: Antonio Rigozzi / Marjolaine Viret / Emily Wisnosky, Does the World Anti-Doping Code Revision Live up to its Promises?, in : Jusletter 11 novembre 2013
Du 12 au 15 novembre 2013 se déroulera, à Johannesburg, la 4è Conférence mondiale sur le dopage et le sport. Dans le cadre de celle-ci, le nouveau Code mondial antidopage (2015 WADA Code) devrait être adopté. Cet article retrace les étapes du processus de consultation qui a abouti au projet final et met en lumière les principales innovations qu’il contient. Les auteurs examinent si et dans quelle mesure les objectifs proclamés au cours du processus de révision ont été atteints. Un regard critique sera aussi porté sur certaines modifications, notamment lorsque leur application pratique paraît problématique. La table en annexe montre l’évolution des articles clés du Code au fil des quatre versions.

Table of contents

  • Introduction
  • I. Technical Issues: Focus on Smarter Evidence-Gathering and Prosecution
  • 1. Emphasis on Intelligence-Based Investigations
  • 1.1. General Remarks
  • A. A Long Awaited Change of Focus
  • B. The Concept of «Intelligence» and «Investigations» under the 2015 WADA Code
  • 1.2. Clearer Definition of Duties and Responsibilities
  • A. Duties of Anti-Doping Organizations
  • B. Cooperation of Other Stakeholders
  • C. Intelligence-Gathering and Privacy
  • 1.3. Instruments to Facilitate Intelligence-Gathering and Investigations
  • A. Substantial Assistance
  • B. Extension of the Statute of Limitations and Data Retention Periods
  • 2. Strengthening the Testing and Analysis Process
  • 2.1. General Remarks
  • 2.2. Smarter Test Distribution and Analysis Menus through Risk Assessment
  • 2.3. Limiting Positive Findings to those Targets Relevant to the Fight against Doping
  • 2.4. Additional Support to Avoid Challenges of Analytical Results
  • A. Presumption of Scientific Validity of Analytical Methods and Decision Limits
  • B. The Cut-Off Point for Further Analyses
  • II. Substantive Issues: Tackling the Real Problems
  • 3. Casting a Bigger Net: Expanding the Means and Scope of Anti-Doping Efforts
  • 3.1. General Remarks
  • 3.2. Evading, Refusing, or Failing to Submit to Sample Collection
  • 3.3. Tampering
  • 3.4. Whereabouts Failures
  • 3.5. Complicity
  • 3.6. More Efficient Means Against Athlete Support Personnel
  • A. General Remarks
  • B. Prohibited Association
  • C. Broadening Jurisdiction and Investigative Obligations Regarding Athlete Support Personnel
  • D. Liability on Athlete Support Personnel for Personal Use and Possession of Prohibited Substances
  • 4. Fine-Tuning the Deterrents: Revisions to the Sanctioning Regime
  • 4.1. General Remarks
  • 4.2. Harsher Penalties for Intentional Dopers
  • A. Increasing the Initial Period of Ineligibility for Intentional Doping
  • a. Version 1.0 Overview
  • b. Version 2.0 Overview
  • c. Versions 3.0 and Final Version 4.0 Overview
  • d. The Definition of «Intentional» in Versions 3.0 and 4.0: Clarification or a Can of Worms?
  • e. Harsher penalties: Full Steam Ahead or Proceed with Caution?
  • B. Prompt Admissions
  • 4.3. More Flexibility for Inadvertent Dopers
  • A. General Remarks
  • B. Specified Substances
  • C. Contaminated Products
  • D. Added Flexibility to the No Significant Fault or Negligence Standard
  • E. Substances of Abuse: Discarded but Not Forgotten
  • 4.4. Fine-Tuning the Sanctioning Regime
  • A. Automatic Publication of Sanctions
  • B. Multiple Violations
  • C. Financial Consequences
  • D. Return for Training
  • 4.5. The Compatibility of the Sanctioning Regime with Recognized Principles of International Law and Human Rights
  • III. Procedural Issues: Fairness
  • 5. Improved Collaboration and Role Clarification among Anti-Doping Organizations
  • 5.1. General Remarks
  • 5.2. Responsibilities for Testing
  • 5.3. Results Management
  • 5.4. Granting Therapeutic Use Exemptions
  • 6. Fair Hearings
  • 6.1. Overview of the Revision of Article 8.1
  • 6.2. The New Wording of Article 8.1: Better Protection or Greater Confusion?
  • 7. Judicial Review before the Court of Arbitration for Sport
  • 7.1. General Remarks
  • 7.2. Single Hearing Before CAS
  • 7.3. Cross Appeals and Other Subsequent Appeals
  • 7.4. De Novo Hearings
  • Annex
  • Annex

Aucun commentaire

Es gibt noch keine Kommentare

Votre commentaire sur cet article

Les abonné-e-s à cette revue peuvent prendre part à la discussion. Veuillez vous connecter pour poster des commentaires.